• Home
  • Solutions
    • Cell sourcing
      • Cell therapy starting material
      • Immunogenetics & bioinformatics
      • Cell therapy supply chain case management
    • Cell therapy supply chain
      • Collection network development
      • Cell delivery & logistics
      • Cell therapy supply chain case management
      • MatchSource software
    • Clinical research support
      • Clinical trial design
      • Observational research
      • Biorepository & sample access
    • Collection network management
    • Quality & regulatory services
    • Quality System Audit Program
    • MatchSource software
    • Outcomes data reporting
  • About Us
    • History
    • Leadership
    • Our Board
    • Our Partners
    • Upcoming Events
    • Join Our Team
    • Contact
  • Cell Lines Blog
  • Resources
    • Webinars
    • Podcast
    • Industry Insights and White Papers
    • Solution Overviews
  • Newsroom
  • Contact Us
  • Twitter
  • LinkedIn
  • Terms of Use
  • Privacy Policy
  • Trademark & Copyright
Be The Match BioTherapies
MENUMENU
  • Solutions
        • Cell sourcing
          • Cell therapy starting material
          • Immunogenetics & bioinformatics
          • Cell therapy supply chain case management
          • MatchSource software
        • Cell therapy supply chain
          • Collection network development
          • Cell delivery & logistics
          • Cell therapy supply chain case management
        • Clinical research support
          • Clinical trial design
          • Observational research
          • Biorepository & sample access
        • Collection network management
        • Outcomes data reporting
        • Quality & regulatory services
        • Quality System Audit Program
  • About Us
    • History
    • Leadership
    • Our Partners
    • Upcoming Events
    • Join Our Team
    • Contact
  • Cell Lines Blog
  • Resources
    • Webinars
    • Podcast
    • Industry Insights and White Papers
    • Solution Overviews
  • Newsroom
  • Contact Us

Information regarding Be The Match BioTherapies response to COVID-19

Cell Lines

You never know… contingency planning in the cell therapy supply chain

A Q&A with Ray Hornung and Cullen Case

Be The Match BioTherapies · Supply Chain · November 14, 2017

Subscribe

Get updates from the Cell Lines Blog delivered to your inbox.

Cell therapies represent some of the most logistically complex treatments ever created, with quality and viability dependent on seamless coordination across multiple steps. With the first CAR-T therapies now approved, and more companies entering this new terrain, managing the cell therapy supply chain has become a mission-critical industry skill. We asked two supply chain experts from our parent company, the National Marrow Donor Program® (NMDP)/Be The Match®, how they manage inevitable interruptions when lives are on the line.

Q: Why is contingency planning important in the cell supply chain?

Cullen Case, senior manager, Logistics and Emergency Preparedness: Successfully delivering cells from a donor or patient to a hospital or manufacturing site is a complex, multi-step process. Because cells must often travel long distances to reach their ultimate destination, interruptions are inevitable, whether it’s a delayed flight or a major incident such as a hurricane that shuts down air transportation in the region or political unrest in a recipient’s home country. Our job is to manage these issues proactively because any unforeseen incident has the potential to disrupt the supply chain.

Ray Hornung, manager, Logistics and Business Continuity: About half of the 20,000 cell and blood sample shipments we oversee each year are shipped internationally. We conduct a constantly playing orchestra to ensure that all the pieces that are needed to support a delivery are always in place. We have team members on call 24 hours a day, so the couriers responsible for transporting our products always have the support of the organization behind them.

Q: How does your team respond to challenges that threaten to interrupt the cell therapy supply chain?

Cullen: When we are alerted to an incident that might disrupt operations, we bring together a collaborative, multi-departmental team to assess what the potential impact might be, then develop an action plan to ensure safe delivery of cells.

Ray: Our ability to respond quickly in a crisis is due in large part to the relationships we have with people and organizations across the supply chain, including hospitals, apheresis centers and cord blood banks. In addition, our personal affiliations within the national and international emergency management communities provide a myriad of contacts to tap when external resources are needed. We rely on a deep network of partnerships developed by NMDP/Be The Match, which has more than 30 years of experience managing more than 92,000 hematopoietic cell transplants across the world. We tap into these personal relationships when we need to enact a contingency plan.

Q: What kinds of disruptions have the organization responded to in the past?

Cullen: In 2010, the eruption of the Icelandic volcano (Eyjafjallajökull) prevented most commercial aircraft from crossing the Atlantic. We called in our contingency planning team, and partnered with other European companies who urgently needed to move products in the U.S. Together, we chartered an aircraft and diverted all our products through Portugal to safely bring them to patients in need.

More recently, during Hurricane Harvey, our team kept a close eye on the storm, and rerouted a number of couriers to ensure they would not be in the hurricane’s path. We had one patient awaiting a transplant in Houston, and a courier lined up to go, but all flights were cancelled. The courier had to fly to San Antonio first, then was rerouted at the last minute to Dallas where he would need to be driven to Houston. Then the emergency manager at Texas Children’s hospital stepped up to help. Although not affiliated with the receiving transplant center in any way, he arranged to have a high-water vehicle standing by (pictured above) if the car transporting the courier ran into issues with flooded roads. Luckily, the car driving the courier was able to make it through and arrived at the transplant center shortly after midnight. The product was successfully infused.

Q: What are you most proud of in your work?

Ray: The cells we collect, transport and deliver are irreplaceable. We use the phrase “one product, one patient” to emphasize just how critical our role within the organization is. Our team is a well-oiled machine. We’re scalable and flexible. We put great care into ensuring that we deliver products safely from the donor to their ultimate destination.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
Tags
Contingency PlanningLogisticsSupply Chain
About the Author
Be The Match BioTherapies

Be The Match BioTherapies

Be The Match BioTherapies partners with organizations pursuing life-saving cellular therapies in every stage of development – from discovery through commercialization. Built on the foundation established over the last 30 years by the National Marrow Donor Program (NMDP)/Be The Match, we have unparalleled experience managing cellular therapies. Our cell therapy supply chain delivery for autologous or allogeneic therapies is enabled by high-touch, personalized case management and a technology platform, MatchSource®. Our experience in cell sourcing and collection allows us to provide cells consented for research, clinical or commercial use. Researchers have access to clinical trial services through our research program CIBMTR. And, we have the infrastructure in place to collect, store and analyze patient samples post-cell or gene therapy treatment at the time points required by regulatory authorities.

More Posts →

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Subscribe

Get updates from the Cell Lines Blog delivered to your inbox.

Close
Be The Match Biotherapies®
  • Terms of Use
  • Privacy Policy
  • Trademark & Copyright
  • Contact

Copyright © 2021 Be The Match BioTherapies. All Rights Reserved.

  • bethematch.org →

    Information and support for patients, donors and supporters of our mission.

  • bethematchclinical.org →

    The latest transplant information for Clinicians, Network, Payers and Bioinformatics.

  • cibmtr.org →

    Transplant research, clinical studies, publications and outcomes data for researchers and clinicians.